Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y6OK
|
|||
| Former ID |
DNC001184
|
|||
| Drug Name |
Quinizarin
|
|||
| Synonyms |
Quinizarin; 1,4-Dihydroxyanthraquinone; 81-64-1; 1,4-dihydroxyanthracene-9,10-dione; Quinizarine; Chinizarin; Solvent Orange 86; 1,4-Dihydroxyanthrachinon; Smoke Orange R; 1,4-Dihydroxy-9,10-anthraquinone; Macrolex Orange GG; 9,10-Anthracenedione, 1,4-dihydroxy-; Anthraquinone, 1,4-dihydroxy-; 1,4-Dioxyanthraquinone; 1,4-Dihydroxyanthra-9,10-quinone; 1,4-Doa; C.I. 58050; 1,4-Doa [Russian]; 1,4-Dihydroxy-anthraquinone; UNII-8S496ZV3CS; NSC 15367; NSC 646569; CCRIS 3524; HSDB 5242; 1,4-Dioxyanthraquinone [Russian]
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H8O4
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)O)O
|
|||
| InChI |
1S/C14H8O4/c15-9-5-6-10(16)12-11(9)13(17)7-3-1-2-4-8(7)14(12)18/h1-6,15-16H
|
|||
| InChIKey |
GUEIZVNYDFNHJU-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 81-64-1
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
540922, 545955, 567309, 581765, 597161, 3134358, 3259730, 5625001, 6410583, 8154325, 10536460, 11405484, 12153388, 15121901, 16252421, 17487284, 22390847, 24863338, 24899334, 25621669, 26531183, 29204051, 29225638, 31526224, 47662624, 47885747, 49870630, 50109933, 50109934, 51074277, 53788211, 57323639, 57903933, 75383990, 85089122, 85247397, 87566949, 88140738, 92710652, 103094645, 103157546, 103181305, 104098258, 104312775, 106142257, 117598204, 117689286, 124645689, 125325029, 125358089
|
|||
| ChEBI ID |
CHEBI:37487
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | DNA topoisomerase I (TOP1) | Target Info | Binder | [1] |
| NetPath Pathway | IL2 Signaling Pathway | |||
| Panther Pathway | DNA replication | |||
| Pathway Interaction Database | Caspase Cascade in Apoptosis | |||
| WikiPathways | Integrated Pancreatic Cancer Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Comparison of responses of DNA topoisomerase I from Candida albicans and human cells to four new agents which stimulate topoisomerase-dependent DNA nicking. FEMS Microbiol Lett. 1996 May 1;138(2-3):105-11. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.